Evidence map›Paper›PMID 30041684›Full record

ArticleGenome medicine2018

Single-cell transcriptome analysis of lineage diversity in high-grade glioma.

Jinzhou Yuan, Hanna Mendes Levitin, Veronique Frattini, Erin C Bush, Deborah M Boyett, Jorge Samanamud, Michele Ceccarelli, Athanassios Dovas, George Zanazzi, Peter Canoll and 4 more

Open access · goldAbstract read
In one paragraph

Article in Genome medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 170 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
170citing papers in PubMed, 1 pooled it
10.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

170 citing papers in PubMed, 1 synthesis or guideline pooled it, 259 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Inherited Susceptibility to Urinary Tract Infections from Kidney Papilla to Bladder.medRxiv : the preprint server for health sciences · 2026
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

110 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 2 institutions in 2 countries.

Jinzhou YuanDepartment of Systems Biology, Columbia University Medical Center, New York, NY, 10032, USA.
Hanna Mendes LevitinDepartment of Systems Biology, Columbia University Medical Center, New York, NY, 10032, USA.
Veronique FrattiniInstitute for Cancer Genetics, Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York, NY, 10032, USA.
Erin C BushDepartment of Systems Biology, Columbia University Medical Center, New York, NY, 10032, USA.
Deborah M BoyettDepartment of Neurological Surgery, Columbia University Medical Center, New York, NY, 10032, USA.
Jorge SamanamudDepartment of Neurological Surgery, Columbia University Medical Center, New York, NY, 10032, USA.
Michele CeccarelliDepartment of Science and Technology, Università degli Studi del Sannio, 82100, Benevento, Italy.
Athanassios DovasDepartment of Pathology & Cell Biology, Columbia University Medical Center, New York, NY, 10032, USA.
George ZanazziDepartment of Pathology & Cell Biology, Columbia University Medical Center, New York, NY, 10032, USA.
Peter CanollDepartment of Pathology & Cell Biology, Columbia University Medical Center, New York, NY, 10032, USA.
Jeffrey N BruceDepartment of Neurological Surgery, Columbia University Medical Center, New York, NY, 10032, USA.
Anna LasorellaInstitute for Cancer Genetics, Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York, NY, 10032, USA.
Antonio IavaroneInstitute for Cancer Genetics, Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York, NY, 10032, USA.
Peter A SimsDepartment of Systems Biology, Columbia University Medical Center, New York, NY, 10032, USA. pas2182@cumc.columbia.edu.ORCID 0000-0002-3921-4837
Columbia University Irving Medical Center · USUniversity of Sannio · IT

Funding

Systematic pharmacological targeting of the core mechanisms responsible for maintaining cancer cell stateU54CA209997 · NCI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI CALIFANO, ANDREA, HONIG, BARRY H · 2016 to 2021
$10.9M
Topology of Cancer Evolution and HeterogeneityU54CA193313 · NCI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI IAVARONE, ANTONIO, RABADAN, RAUL · 2015 to 2020
$10.4M
TRAINING IN CELLULAR, MOLECULAR AND BIOPHYSICAL STUDIEST32GM008224 · NIGMS · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI LIEM, RONALD K. · 1987 to 2021
$9.9M
Systematic Identification and Pharmacological Targeting of Tumor Dependencies for Precision Cancer MedicineU01CA217858 · NCI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI CALIFANO, ANDREA · 2017 to 2021
$6.1M
Single Cell Analysis of the Infiltrative Margins of Glioblastoma and Post Treatment RecurrenceR01NS103473 · NINDS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI JEFFREY N BRUCE, Peter Canoll · 2017 to 2026
$4.3M
A Microfluidic System for Image-Guided RNA-Seq of Single Cells in GlioblastomaK01EB016071 · NIBIB · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI SIMS, PETER ALAN · 2012 to 2016
$863k
NCI NIH HHS U01 CA217858NCI NIH HHS U54 CA193313NCI NIH HHS U54CA193313NCI NIH HHS U54 CA209997NCI NIH HHS U54CA209997NIBIB NIH HHS K01 EB016071NIBIB NIH HHS K01EB016071NIGMS NIH HHS T32 GM008224NINDS NIH HHS R01 NS103473NINDS NIH HHS R01NS103473
6 · The paper itself

Abstract

backgroundDespite extensive molecular characterization, we lack a comprehensive understanding of lineage identity, differentiation, and proliferation in high-grade gliomas (HGGs).

methodsWe sampled the cellular milieu of HGGs by profiling dissociated human surgical specimens with a high-density microwell system for massively parallel single-cell RNA-Seq. We analyzed the resulting profiles to identify subpopulations of both HGG and microenvironmental cells and applied graph-based methods to infer structural features of the malignantly transformed populations.

resultsWhile HGG cells can resemble glia or even immature neurons and form branched lineage structures, mesenchymal transformation results in unstructured populations. Glioma cells in a subset of mesenchymal tumors lose their neural lineage identity, express inflammatory genes, and co-exist with marked myeloid infiltration, reminiscent of molecular interactions between glioma and immune cells established in animal models. Additionally, we discovered a tight coupling between lineage resemblance and proliferation among malignantly transformed cells. Glioma cells that resemble oligodendrocyte progenitors, which proliferate in the brain, are often found in the cell cycle. Conversely, glioma cells that resemble astrocytes, neuroblasts, and oligodendrocytes, which are non-proliferative in the brain, are generally non-cycling in tumors.

conclusionsThese studies reveal a relationship between cellular identity and proliferation in HGG and distinct population structures that reflects the extent of neural and non-neural lineage resemblance among malignantly transformed cells.

Indexed as

Single-Cell AnalysisTranscriptomeBrain NeoplasmsCell ProliferationCell Transformation, NeoplasticGliomaHumansNeurogliaNeurons

Identifiers

PMID30041684
PMCPMC6058390
OpenAlexW2883808647

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.